Clinical pharmacology

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS11
Academic Journal
Presents an abstract of the research manuscript `Spurious increases in blood lipid levels during furosemide therapy. A randomized double blind placebo controlled cross-over study,' by N.R.C. Campbell, R. Brant et al from the University of Calgary.


Related Articles

  • Disseminated Superficial Porokeratosis Induced by Furosemide. Kroiss, Maximilian; Stolz, Wilhelm; Hohenleutner, Ulrich; Landthaler, Michael // Acta Dermato-Venereologica;Jan2000, Vol. 80 Issue 1, p52 

    Describes a case of disseminated superficial porokeratosis induced by furosemide. Clinical characteristics of the disease; Exacerbation of the disease by non-immunosuppressive drugs; Prevalence of photosensitivity and phototoxic reactions during furosemide therapy.

  • A Population-Based Case-Control Teratological Study of Furosemide Treatment during Pregnancy. Czeizel, A.E.; Rockenbauer, M. // Clinical Drug Investigation;1999, Vol. 18 Issue 4, p307 

    Objective: To study the human teratogenic potential of furosemide (frusemide) treatment during pregnancy. Design and Setting: This study used pair analysis of newborn infants with congenital abnormalities and matched healthy controls. Cases and controls were from the large population-based...

  • Furosemide/hydrochlorothiazide/triamterene.  // Reactions Weekly;12/11/2010, Issue 1331, p17 

    The article describes the case of a 76-year-old patient who developed hyponatraemia which led to apical ballooning syndrome while undergoing treatment with furosemide, hydrochlorothiazide and triamtrene.

  • Digoxin/furosemide interaction.  // Reactions Weekly;5/15/2010, Issue 1301, p19 

    The article describes the case of a 23-year-old man who acquired gynaecomastia in his left breast while undergoing treatment with digoxin and furosemide.

  • Enalapril/furosemide.  // Reactions Weekly;2/12/2011, Issue 1338, p18 

    The article describes the case of an elderly woman who developed renal failure while undergoing treatment with enalapril and furosemide.

  • Renal Hypoprostaglandism, Hypertension, and Type IV Renal Tubular Acidosis Reversed by Furosemide. Sanjad, Sami A.; Keenan, Bruce S.; Hill, L. Leighton // Annals of Internal Medicine;Nov83, Vol. 99 Issue 5, p624 

    Presents information on a study which examined the therapeutic effect of furosemide on renal hypoprostaglandism, hypertension and type IV renal tubular acidosis. Methodology; Results; Discussion.

  • Diuretic Properties of Furosemide in Renal Disease. Muel, Robert G. // Annals of Internal Medicine;Aug68, Vol. 69 Issue 2, p249 

    Investigates the diuretic properties of furosemide in renal disease. Medical cases of patients with renal disease; Oral therapy of furosemide; Results of case studies.

  • Intravenous infusion of frusemide as treatment for ascites in malignant disease. Miel, Stephanie A.; Blackburn, Ann M. // British Medical Journal (Clinical Research Edition);4/7/1984, Vol. 288 Issue 6423, p1041 

    Examines the effectiveness of intravenous infusion of frusemide in treating ascites in malignant disease in Great Britain. Essence of frusemide in the management of renal and cardiac failure; Diagnosis of a patient with serous papillary cystadenocarcinoma; Failure of patient to respond to...

  • Furosemide-Induced Reduction in Ionized Calcium in Hypoparathyroid Patients. Gabow, Patricia A.; Hanson, Thomas J.; Popovtzer, Mordecai M.; Schrier, Robert W. // Annals of Internal Medicine;May77, Vol. 86 Issue 5, p579 

    Details a study which assessed the efficacy of oral furosemide in treating hypoparathyroid. Impact of furosemide on serum ionized calcium level; Clinical characteristics of the study population; Therapeutic significance of oral furosemide.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics